However, LASSBio-294 is an A2AR agonist that showed a positive effect on heart and significantly reduced hypertension associated with MI and decreased collagen deposition and TNFα levels in the left ventricle, thus inhibiting fibrosis [141]. Here, ADORA2A is linked to myocardial infarction.